Metabolic syndrome in the elderly refers to a cluster of metabolic disturbances,characterized by a high comorbidity incidence,varied clinical presentations,intricate mechanisms,and the involvement of polypharmacy,which elevates the risk of adverse drug reactions.Metabolic syndrome severely undermines the quality of life and health among the elderly,placing a significant burden on healthcare system and society in China.Expert Consensus on Drug Treatment for Metabolic Syndrome in the Elderly in China(2022)thoroughly reviewed and summarized the diagnostic criteria and therapeutic objectives for metabolic syndrome in the elderly,provided the latest medications and their inter-actions,and offered ten recommendation points.This document interprets the key points of the consensus,particularly in terms of pharmacological treatment,and aims to provide relevant references for the decision-making process in the phar-macological management and health care for elderly individuals with metabolic syndrome.
Metabolic syndromeMultiple chronic conditionsDrug therapyQuality of lifeAged
维普
万方数据
